Vital Farms stock gained 2.10 percent ahead of November results

Published on 10/06/2026 at 09:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Vital Farms stock gained 2.10 percent to USD 9.25 on October 5, 2026, before the next results date. Q2 revenue fell 10.1 percent to USD 166.03 million.

VITL, US92847W1036, Illustration mit AI erstellt.

Vital Farms stock gained 2.10 percent to USD 9.25 on Nasdaq on October 5, 2026, while the company heads toward its next earnings date on November 5. The move came against a difficult operating backdrop: second-quarter revenue fell 10.1 percent year over year to USD 166.03 million, and the company reported a USD 31.07 million net loss.

Losses reshape the investment case

According to Substack, Vital Farms published the Q2 2026 figures on August 6, 2026, with revenue of USD 166.0 million and a gross margin of 6.6 percent. Gross margin had been 38.9 percent in the year-earlier quarter, while net income of USD 16.6 million turned into a USD 31.1 million loss.

The finance figures show the same pressure in more precise terms: Q2 diluted earnings per share were negative USD 0.72, compared with negative USD 0.03 in the first quarter of 2026. Operating cash flow was negative USD 27.36 million in the quarter ended June 28, 2026, adding a liquidity dimension to the earnings decline.

Analysts see room above USD 9.25

According to MarketBeat on September 19, 2026, 14 research firms had a consensus Hold rating, with five Buy ratings, eight Hold ratings and one Sell rating. The average 12-month price target was USD 17.18, placing the target USD 7.93 above the October 5 price, or 85.7 percent higher.

Individual views remain more constructive than the consensus label. Markets Insider reported on September 24, 2026, that Jefferies maintained a Buy rating and a USD 15.00 price target. That target stood USD 5.75 above the October 5 price, equivalent to 62.2 percent.

November results set the next test

Yahoo Finance lists November 5, 2026, as Vital Farms' next earnings date. The release will show whether the company can convert its stated supply-demand improvements into a recovery in gross margin and cash generation.

On October 5, the stock traded between USD 8.86 and USD 9.37, with volume of 1,777,400 shares. Its USD 396.3 million market capitalization and the USD 7.95 to USD 45.16 52-week range frame a company whose current valuation remains far below its yearly peak, even as the next quarterly report approaches.